Erna Cleiren

1.9k total citations
16 papers, 1.2k citations indexed

About

Erna Cleiren is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Erna Cleiren has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Oncology. Recurrent topics in Erna Cleiren's work include Wnt/β-catenin signaling in development and cancer (6 papers), Connective tissue disorders research (4 papers) and Trace Elements in Health (3 papers). Erna Cleiren is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (6 papers), Connective tissue disorders research (4 papers) and Trace Elements in Health (3 papers). Erna Cleiren collaborates with scholars based in Belgium, United States and Denmark. Erna Cleiren's co-authors include Wim Van Hul, Liesbeth Van Wesenbeeck, Matthew L. Warman, Wendy Balemans, Jeppe Gram, Jens Bollerslev, Domenico Scopelliti, Marie‐Christine de Vernejoul, Olivier Bénichou and Rodney K. Beals and has published in prestigious journals such as Journal of Virology, The American Journal of Human Genetics and Human Molecular Genetics.

In The Last Decade

Erna Cleiren

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erna Cleiren Belgium	12	927	379	366	191	97	16	1.2k
Lyle E. Pegg United States	11	431 0.5×	103 0.3×	162 0.4×	39 0.2×	63 0.6×	17	873
David G. Winkler United States	13	612 0.7×	82 0.2×	218 0.6×	128 0.7×	73 0.8×	14	855
Matteo M. Guerrini Japan	9	394 0.4×	87 0.2×	191 0.5×	62 0.3×	124 1.3×	12	581
Ryan L. Kelly United States	20	899 1.0×	99 0.3×	222 0.6×	21 0.1×	261 2.7×	25	1.6k
Fuminori Hirano Japan	13	335 0.4×	61 0.2×	221 0.6×	15 0.1×	23 0.2×	23	742
Elizabeth A. Saria United States	15	308 0.3×	165 0.4×	284 0.8×	13 0.1×	34 0.4×	27	810
Alexei Miagkov United States	10	330 0.4×	95 0.3×	157 0.4×	10 0.1×	149 1.5×	13	700
Christine Huard United States	13	648 0.7×	117 0.3×	302 0.8×	9 0.0×	31 0.3×	16	1.4k
Satoko Kinoshita Japan	8	667 0.7×	417 1.1×	81 0.2×	12 0.1×	40 0.4×	14	1.3k
Ho Lam Chan United States	14	674 0.7×	88 0.2×	406 1.1×	25 0.1×	6 0.1×	20	1.2k

Countries citing papers authored by Erna Cleiren

Since Specialization

Citations

This map shows the geographic impact of Erna Cleiren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erna Cleiren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erna Cleiren more than expected).

Fields of papers citing papers by Erna Cleiren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erna Cleiren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erna Cleiren. The network helps show where Erna Cleiren may publish in the future.

Co-authorship network of co-authors of Erna Cleiren

This figure shows the co-authorship network connecting the top 25 collaborators of Erna Cleiren. A scholar is included among the top collaborators of Erna Cleiren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erna Cleiren. Erna Cleiren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cleiren, Erna, et al.. (2019). Influence of the bispecific antibody IgG subclass on T cell redirection. mAbs. 11(6). 1012–1024. 11 indexed citations

Rombouts, Frederik, Richard Alexander, Erna Cleiren, et al.. (2017). Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches. ACS Omega. 2(2). 685–697. 13 indexed citations

Cleiren, Erna, Benoit Devogelaere, & Katleen Fierens. (2013). Surface Plasmon Resonance as a Tool to Select Potent Drug Candidates for Hepatitis C Virus NS5B Polymerase. Methods in molecular biology. 1030. 129–136.

Devogelaere, Benoit, Jan Martin Berke, Leen Vijgen, et al.. (2012). TMC647055, a Potent Nonnucleoside Hepatitis C Virus NS5B Polymerase Inhibitor with Cross-Genotypic Coverage. Antimicrobial Agents and Chemotherapy. 56(9). 4676–4684. 31 indexed citations

Balemans, Wendy, Elke Piters, Erna Cleiren, et al.. (2008). The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations. Calcified Tissue International. 82(6). 445–453. 113 indexed citations

Pauwels, Frederik, Wendy Mostmans, Liesbet van der Helm, et al.. (2007). Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus Polymerase Inhibitors. Journal of Virology. 81(13). 6909–6919. 55 indexed citations

Balemans, Wendy, et al.. (2007). Novel LRP5 Missense Mutation in a Patient With a High Bone Mass Phenotype Results in Decreased DKK1-Mediated Inhibition of Wnt Signaling*. Journal of Bone and Mineral Research. 22(5). 708–716. 65 indexed citations

Wuyts, Wim, et al.. (2006). Identification and Molecular Characterization of a Novel Splice-Site Mutation (G1205C) in the SQSTM1 Gene Causing Paget’s Disease of Bone in an Extended American Family. Calcified Tissue International. 79(5). 281–288. 19 indexed citations

Balemans, Wendy, J. P. Devogelaer, Erna Cleiren, & Wim Van Hul. (2006). A novel LRP5 mutation in a patient with increased bone mass results in reduced DKK1-inhibition. Bone. 38(3). 6–7. 4 indexed citations

10.

Kwee, M. L., et al.. (2005). An autosomal dominant high bone mass phenotype in association with craniosynostosis in an extended family is caused by an LRP5 missense mutation. Bone and Mineral. 20(7). 3 indexed citations

11.

Balemans, Wendy, et al.. (2005). A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the gene. Bone. 36(6). 943–947. 55 indexed citations

12.

Balemans, Wendy, Andy Willaert, Inge Van Pottelbergh, et al.. (2005). Missense Mutations in LRP5 Are Not a Common Cause of Idiopathic Osteoporosis in Adult Men. Journal of Bone and Mineral Research. 20(11). 1951–1959. 21 indexed citations

13.

Kwee, M. L., et al.. (2005). An Autosomal Dominant High Bone Mass Phenotype in Association With Craniosynostosis in an Extended Family Is Caused by an LRP5 Missense Mutation. Journal of Bone and Mineral Research. 20(7). 1254–1260. 38 indexed citations

14.

Wesenbeeck, Liesbeth Van, Erna Cleiren, Jeppe Gram, et al.. (2003). Six Novel Missense Mutations in the LDL Receptor-Related Protein 5 (LRP5) Gene in Different Conditions with an Increased Bone Density. The American Journal of Human Genetics. 72(3). 763–771. 426 indexed citations

15.

Bénichou, Olivier, et al.. (2001). Mapping of Autosomal Dominant Osteopetrosis Type II (Albers-Schönberg Disease) to Chromosome 16p13.3. The American Journal of Human Genetics. 69(3). 647–654. 47 indexed citations

16.

Cleiren, Erna. (2001). Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Human Molecular Genetics. 10(25). 2861–2867. 270 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact